July 21, 2020
Article
The American Oncology Network, LLC, has added 5 medical oncologists to its Executive Committee.
July 20, 2020
Article
“We’ve had advancements, but we need to go faster,” said ASCO President Howard A. "Skip" Burris III, MD, as he stressed the importance of advancing therapies for better patient outcomes by addressing obstacles to patients’ care. “Access to care, access to clinical trials, and access to information are really key.”
July 14, 2020
Article
Nathan H. Walcker will succeed Brad Prechtl on August 1, 2020.
July 01, 2020
Article
Both the federal government and state officials have implemented policies and safeguards to slow transmission of the virus. Perhaps most troubling in this new environment were the state moratoriums on “elective” surgical procedures.
June 19, 2020
Article
As I recall the early days of the HIV/AIDS pandemic, what stands out most is its profound human cost and the courage of those who helped our society transcend it. We are in the midst of a time in which the human toll of COVID-19 and the enormity of the path ahead are clear.
June 17, 2020
Article
Coverage from the Community Oncology Alliance Virtual Meeting, held April 23-24, 2020.
June 17, 2020
Article
The American Society of Clinical Oncology recommends that cancer survivors who have completed their treatment and are under surveillance with no known evidence of disease are to be kept out of care facilities to avoid developing COVID-19.
June 16, 2020
Article
Investigators reported in Lancet Oncology that second-line treatments are needed in small cell lung cancer, as few options exist for these patients once first-line therapy fails.
June 11, 2020
Article
The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.
June 11, 2020
Video
Benchmarking, accountability, bilateralism, and scalability are the 4 parameters critical to successful alternative payment models in oncology, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.